Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
COLL compared with LLY: revenue, margins and what each company keeps, and the suppliers and customers both name
COLL
Collegium Pharmaceutical, Inc
Change
Mkt cap
Revenue
Revenue
LLY
ELI Lilly & Co
Change
Mkt cap
Revenue
Revenue
vs
Compare
COLL
Collegium Pharmaceutical, Inc
vs
LLY
ELI Lilly & Co
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Earnings history
Desk
News
Calendar
Saved
Search
Earnings history
last 4 reports each · paired by recency
Method
›
COLL
1 of 4
at or beyond implied
Report
implied
realized
× implied
Q3 FY26
thin chain
±20.4%
▲
+6.29%
×0.31
Q2 FY26
±12.2%
▼
−18.55%
×1.52
May 7 '26
±12.6%
▲
+7.72%
×0.61
Q1 FY26
±7.7%
▼
−3.34%
×0.43
LLY
3 of 4
at or beyond implied
Report
implied
realized
× implied
Q3 FY26
±5.1%
▲
+6.63%
×1.29
Q2 FY26
±6.2%
▲
+4.86%
×0.79
= implied
COLL realized, solid
LLY realized, hatched
One scale, both sides: full bar = 21%
× = |realized| ÷ implied
Source: market data
Q1 FY26
±5.3%
▲
+9.80%
×1.85
Feb 4 '26
±6.1%
▲
+10.33%
×1.69
COLL
Collegium Pharmaceutical, Inc
Change
24.23
▼
−3.71%
· post 24.23
Mkt cap
$752.3M
Revenue
$216M
Q3 FY26
Revenue
$781M
FY25
LLY
ELI Lilly & Co
Change
1,360.90
▼
−0.28%
· post 1,358.90
Closed
Nov 6 '26
Mkt cap
$1.2T
Revenue
$24.4B
Q3 FY26
Revenue
$65.2B
FY25
vs
Compare
Closed
Nov 6 '26
COLL
Collegium Pharmaceutical, Inc
vs
LLY
ELI Lilly & Co
24.23
▼
−3.71%
post 24.23
Price
1,360.90
▼
−0.28%
post 1,358.90
$752.3M
Mkt cap
$1.2T
Q3 FY26
$216M
Revenue
$24.4B
Q3 FY26
FY25
$781M
Revenue
$65.2B
FY25
Change
Change
COLL
24.23
▼
−3.71%
vs
LLY
1,360.90
▼
−0.28%
Closed
Nov 6 '26